PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 1 month ago Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day Salix Pharmaceuticals, Bausch Health Companies Inc., U.S. Pain Foundation, and IFFGD collaborate to establish the first annual Opioid-Induced Constipation (OIC) Awareness Day to raise awareness about the often-overlooked side effect of opioids and provide a platform for patients, caregivers, and healthcare providers to discuss and address OIC Healthcare Providers Chronic Pain Opioid-Induced Constipation Awareness Day Patient Advocacy
PRESS RELEASE published on 11/10/2023 at 14:00, 2 years 2 months ago The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/10/2023 at 06:00, 2 years 2 months ago CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/08/2023 at 14:00, 2 years 2 months ago As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 11/02/2023 at 12:00, 2 years 2 months ago Bausch Health Announces Third-Quarter 2023 Results
PRESS RELEASE published on 11/01/2023 at 17:22, 2 years 3 months ago U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
PRESS RELEASE published on 10/26/2023 at 14:00, 2 years 3 months ago Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 10/20/2023 at 23:20, 2 years 3 months ago FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 3 months ago New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
PRESS RELEASE published on 10/12/2023 at 14:00, 2 years 3 months ago Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
Published on 01/31/2026 at 03:15, 1 day 15 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 17 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 20 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 1 day 3 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 6 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 16 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 21 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 22 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 17:45, 2 days 1 hour ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 3 days 1 hour ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 1 hour ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 3 days 1 hour ago Cegedim generated LFL revenue growth of 1.1% in 2025
